var singsData = [{"date":new Date(2012,1,14),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup downgrades BAC to Neutral from Buy. Target Price is $8.5; previously $8.","showOnAxis":true},{"date":new Date(2012,1,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains BAC to Neutral. Target Price is $8; previously $7.","showOnAxis":true},{"date":new Date(2012,1,29),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.01","showOnAxis":true},{"date":new Date(2012,10,19),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Stifel Nicolaus upgrades BAC to Buy from Hold.","showOnAxis":false},{"date":new Date(2012,10,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"ISI Group upgrades BAC to Buy from Hold. Target Price is $12.","showOnAxis":false},{"date":new Date(2012,11,5),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.01","showOnAxis":true},{"date":new Date(2012,11,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"SunTrust Robinson Humphrey initiates coverage on BAC to Neutral. Target Price is $11.","showOnAxis":true},{"date":new Date(2012,2,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains BAC to Equal-Weight. Target Price is $9; previously $7.","showOnAxis":true},{"date":new Date(2012,2,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BAC to Hold. Target Price is $9; previously $7.5.","showOnAxis":true},{"date":new Date(2012,2,31),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2012 Q1's earning $0.03 per share and revenue $26893MM..","showOnAxis":false},{"date":new Date(2012,3,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains BAC to Overweight. Target Price is $11.5; previously $10.5.","showOnAxis":true},{"date":new Date(2012,3,11),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Guggenheim upgrades BAC to Buy from Neutral. Target Price is $11.","showOnAxis":false},{"date":new Date(2012,3,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains BAC to Neutral. Target Price is $10; previously $8.","showOnAxis":true},{"date":new Date(2012,3,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains BAC to Neutral. Target Price is $9; previously $8.5.","showOnAxis":true},{"date":new Date(2012,4,22),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Sterne Agee maintains BAC to Neutral. Target Price is $8; previously $10.","showOnAxis":true},{"date":new Date(2012,4,30),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.01","showOnAxis":true},{"date":new Date(2012,5,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains BAC to Neutral. Target Price is $7.5; previously $10.","showOnAxis":true},{"date":new Date(2012,6,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bernstein maintains BAC to Market Perform. Target Price is $9; previously $9.5.","showOnAxis":true},{"date":new Date(2012,6,18),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2012 Q2's earning $0.19 per share and revenue $22200MM. This beats analyst's estimated EPS $0.14, misses estimated revenue $22870MM.","showOnAxis":false},{"date":new Date(2012,6,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"ISI Group maintains BAC to Hold. Target Price is $8; previously $9.","showOnAxis":true},{"date":new Date(2012,8,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains BAC to Neutral. Target Price is $10; previously $8.5.","showOnAxis":true},{"date":new Date(2012,8,5),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.01","showOnAxis":true},{"date":new Date(2012,9,17),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2012 Q3's earning $0 per share and revenue $20400MM. This beats analyst's estimated EPS $-0.07, misses estimated revenue $21890MM.","showOnAxis":false},{"date":new Date(2012,9,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"ISI Group maintains BAC to Hold. Target Price is $10; previously $9.","showOnAxis":true},{"date":new Date(2012,9,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains BAC to Neutral. Target Price is $9; previously $8.","showOnAxis":true},{"date":new Date(2012,9,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Sterne Agee maintains BAC to Neutral. Target Price is $10; previously $9.","showOnAxis":true},{"date":new Date(2012,9,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains BAC to Neutral. Target Price is $9.5; previously $8.","showOnAxis":true},{"date":new Date(2012,9,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Drexel Hamilton initiates coverage on BAC to Buy. Target Price is $11.","showOnAxis":true},{"date":new Date(2013,0,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains BAC to Neutral. Target Price is $11.5; previously $9.5.","showOnAxis":true},{"date":new Date(2013,0,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Sandler O'Neill downgrades BAC to Hold from Buy.","showOnAxis":true},{"date":new Date(2013,0,17),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2012 Q4's earning $0.03 per share and revenue $18660MM. This beats analyst's estimated EPS $0.02, misses estimated revenue $21030MM.","showOnAxis":false},{"date":new Date(2013,0,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains BAC to Neutral. Target Price is $12; previously $10.","showOnAxis":true},{"date":new Date(2013,0,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains BAC to Neutral. Target Price is $11.25; previously $9.","showOnAxis":true},{"date":new Date(2013,0,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BAC to Hold. Target Price is $11; previously $9.","showOnAxis":true},{"date":new Date(2013,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Goldman Sachs maintains BAC to Neutral. Target Price is $12.5; previously $12.","showOnAxis":true},{"date":new Date(2013,0,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"ISI Group maintains BAC to Buy. Target Price is $14; previously $13.","showOnAxis":true},{"date":new Date(2013,0,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains BAC to Overweight. Target Price is $13.5; previously $13.","showOnAxis":true},{"date":new Date(2013,0,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse downgrades BAC to Neutral from Outperform. Target Price is $12; previously $11.","showOnAxis":true},{"date":new Date(2013,1,27),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.01","showOnAxis":true},{"date":new Date(2013,1,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Rafferty initiates coverage on BAC to Buy. Target Price is $14.75.","showOnAxis":true},{"date":new Date(2013,10,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Bernstein maintains BAC to Market Perform. Target Price is $15.","showOnAxis":true},{"date":new Date(2013,11,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Guggenheim maintains BAC to Neutral. Target Price is $17; previously $16.","showOnAxis":true},{"date":new Date(2013,11,4),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.01","showOnAxis":true},{"date":new Date(2013,2,15),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Scotiabank upgrades BAC to Sector Outperform from Sector Perform.","showOnAxis":false},{"date":new Date(2013,2,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Edward Jones upgrades BAC to Buy from Hold.","showOnAxis":false},{"date":new Date(2013,3,17),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2013 Q1's earning $0.2 per share and revenue $23850MM. This misses analyst's estimated EPS $0.22, beats estimated revenue $23500MM.","showOnAxis":false},{"date":new Date(2013,3,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains BAC to Equal-Weight. Target Price is $13; previously $10.","showOnAxis":true},{"date":new Date(2013,3,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura maintains BAC to Neutral. Target Price is $12; previously $11.25.","showOnAxis":true},{"date":new Date(2013,3,18),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS maintains BAC to Neutral. Target Price is $12; previously $11.5.","showOnAxis":true},{"date":new Date(2013,3,23),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Morgan Stanley upgrades BAC to Overweight from Equal-Weight. Target Price is $16; previously $13.","showOnAxis":false},{"date":new Date(2013,4,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BAC to Hold. Target Price is $13; previously $11.","showOnAxis":true},{"date":new Date(2013,4,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods downgrades BAC to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2013,5,5),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.01","showOnAxis":true},{"date":new Date(2013,5,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Macquarie initiates coverage on BAC to Underperform. Target Price is $12.","showOnAxis":true},{"date":new Date(2013,6,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains BAC to Overweight. Target Price is $14.5; previously $13.5.","showOnAxis":true},{"date":new Date(2013,6,17),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2013 Q2's earning $0.32 per share and revenue $22900MM. This beats analyst's estimated EPS $0.25, beats estimated revenue $22790MM.","showOnAxis":false},{"date":new Date(2013,7,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains BAC to Neutral. Target Price is $14; previously $13.","showOnAxis":true},{"date":new Date(2013,8,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Societe Generale initiates coverage on BAC to Buy. Target Price is $17.","showOnAxis":true},{"date":new Date(2013,8,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Guggenheim downgrades BAC to Neutral from Buy.","showOnAxis":true},{"date":new Date(2013,8,4),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.01","showOnAxis":true},{"date":new Date(2013,9,16),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2013 Q3's earning $0.2 per share and revenue $21700MM. This beats analyst's estimated EPS $0.18, misses estimated revenue $22080MM.","showOnAxis":false},{"date":new Date(2013,9,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Baird maintains BAC to Neutral. Target Price is $15; previously $14.","showOnAxis":true},{"date":new Date(2013,9,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Raymond James downgrades BAC to Outperform from Strong Buy. Target Price is $16; previously $16.5.","showOnAxis":true},{"date":new Date(2014,0,15),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2013 Q4's earning $0.29 per share and revenue $21490MM. This beats analyst's estimated EPS $0.27, beats estimated revenue $21280MM.","showOnAxis":false},{"date":new Date(2014,0,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Raymond James maintains BAC to Outperform. Target Price is $20; previously $17.","showOnAxis":true},{"date":new Date(2014,0,2),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Citigroup upgrades BAC to Buy from Neutral. Target Price is $19; previously $16.","showOnAxis":false},{"date":new Date(2014,0,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies initiates coverage on BAC to Buy. Target Price is $19.","showOnAxis":true},{"date":new Date(2014,0,9),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura initiates coverage on BAC to Buy. Target Price is $19.","showOnAxis":true},{"date":new Date(2014,11,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Guggenheim initiates coverage on BAC to Buy. Target Price is $20.","showOnAxis":true},{"date":new Date(2014,11,3),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.05","showOnAxis":true},{"date":new Date(2014,2,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Atlantic Equities downgrades BAC to Neutral from Overweight.","showOnAxis":true},{"date":new Date(2014,2,5),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.01","showOnAxis":true},{"date":new Date(2014,3,17),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Oppenheimer upgrades BAC to Outperform from market perform. Target Price is $19.","showOnAxis":false},{"date":new Date(2014,3,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BAC to Buy. Target Price is $18.5; previously $20.","showOnAxis":true},{"date":new Date(2014,3,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Morgan Stanley maintains BAC to Overweight. Target Price is $20; previously $21.","showOnAxis":true},{"date":new Date(2014,3,24),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BAC to Hold. Target Price is $16.5; previously $15.","showOnAxis":true},{"date":new Date(2014,3,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"SunTrust Robinson Humphrey maintains BAC to Neutral. Target Price is $17; previously $19.","showOnAxis":true},{"date":new Date(2014,3,29),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains BAC to Overweight. Target Price is $17.5; previously $18.","showOnAxis":true},{"date":new Date(2014,4,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Portales Partners upgrades BAC to Sector Perform from Underperform.","showOnAxis":false},{"date":new Date(2014,4,12),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BAC to Buy. Target Price is $18; previously $18.5.","showOnAxis":true},{"date":new Date(2014,4,21),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"MKM Partners initiates coverage on BAC to Buy. Target Price is $18.","showOnAxis":true},{"date":new Date(2014,5,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains BAC to Overweight. Target Price is $17; previously $17.5.","showOnAxis":true},{"date":new Date(2014,5,20),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.01","showOnAxis":true},{"date":new Date(2014,6,16),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2014 Q2's earning $0.41 per share and revenue $21960MM. This beats analyst's estimated EPS $0.3, beats estimated revenue $21710MM.","showOnAxis":false},{"date":new Date(2014,6,2),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Deutsche Bank upgrades BAC to Buy from Hold. Target Price is $18; previously $16.5.","showOnAxis":false},{"date":new Date(2014,8,3),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.05","showOnAxis":true},{"date":new Date(2014,8,3),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Nomura downgrades BAC to Neutral from Buy.","showOnAxis":true},{"date":new Date(2014,8,4),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains BAC to Overweight. Target Price is $17.5; previously $17.","showOnAxis":true},{"date":new Date(2014,8,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Goldman Sachs upgrades BAC to Buy from Neutral.","showOnAxis":false},{"date":new Date(2014,9,16),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"FBR Capital upgrades BAC to Outperform from Market Perform. Target Price is $20; previously $18.","showOnAxis":false},{"date":new Date(2014,9,2),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"UBS upgrades BAC to Buy from Neutral.","showOnAxis":false},{"date":new Date(2015,0,15),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2014 Q4's earning $0.32 per share and revenue $18725MM. This meets analyst's estimated EPS $0.32, misses estimated revenue $20940MM.","showOnAxis":false},{"date":new Date(2015,0,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BAC to Buy. Target Price is $19; previously $20.","showOnAxis":true},{"date":new Date(2015,0,5),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains BAC to Equal-Weight. Target Price is $20; previously $18.","showOnAxis":true},{"date":new Date(2015,0,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse initiates coverage on BAC to Overweight. Target Price is $21.","showOnAxis":true},{"date":new Date(2015,1,27),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS downgrades BAC to Neutral from Buy.","showOnAxis":true},{"date":new Date(2015,11,2),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.05","showOnAxis":true},{"date":new Date(2015,2,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer maintains BAC to Outperform. Target Price is $22; previously $21.","showOnAxis":true},{"date":new Date(2015,2,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Raymond James assumes BAC to Outperform. Target Price is $18.","showOnAxis":true},{"date":new Date(2015,2,2),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains BAC to Buy. Target Price is $18; previously $19.","showOnAxis":true},{"date":new Date(2015,2,4),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.05","showOnAxis":true},{"date":new Date(2015,3,15),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2015 Q1's earning $0.27 per share and revenue $21202MM. This misses analyst's estimated EPS $0.3, misses estimated revenue $21640MM.","showOnAxis":false},{"date":new Date(2015,3,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BMO Capital maintains BAC to Outperform. Target Price is $18; previously $19.","showOnAxis":true},{"date":new Date(2015,3,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains BAC to Equal-Weight. Target Price is $19; previously $20.","showOnAxis":true},{"date":new Date(2015,3,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BAC to Buy. Target Price is $18; previously $19.","showOnAxis":true},{"date":new Date(2015,3,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer maintains BAC to Outperform. Target Price is $21; previously $22.","showOnAxis":true},{"date":new Date(2015,4,28),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Portales Partners downgrades BAC to Sector Perform from Outperform.","showOnAxis":true},{"date":new Date(2015,4,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"BMO Capital downgrades BAC to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2015,5,3),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.05","showOnAxis":true},{"date":new Date(2015,6,15),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2015 Q2's earning $0.45 per share and revenue $22345MM. This beats analyst's estimated EPS $0.36, beats estimated revenue $21300MM.","showOnAxis":false},{"date":new Date(2015,6,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods maintains BAC to Market Perform. Target Price is $20; previously $17.","showOnAxis":true},{"date":new Date(2015,6,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BAC to Buy. Target Price is $21.","showOnAxis":true},{"date":new Date(2015,6,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"RBC Capital maintains BAC to Outperform. Target Price is $20; previously $19.","showOnAxis":true},{"date":new Date(2015,7,24),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Keefe Bruyette & Woods upgrades BAC to Outperform from Market Perform. Target Price is $20.","showOnAxis":false},{"date":new Date(2015,7,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Baird upgrades BAC to Outperform from Neutral.","showOnAxis":false},{"date":new Date(2015,7,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Bernstein upgrades BAC to Outperform from Neutral. Target Price is $19.","showOnAxis":false},{"date":new Date(2015,7,25),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Macquarie upgrades BAC to Neutral from Underperform.","showOnAxis":false},{"date":new Date(2015,7,26),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"UBS upgrades BAC to Buy from Neutral. Target Price is $20; previously $18.","showOnAxis":false},{"date":new Date(2015,8,2),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.05","showOnAxis":true},{"date":new Date(2015,8,8),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Nomura upgrades BAC to Buy from Neutral.","showOnAxis":false},{"date":new Date(2015,9,6),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Oppenheimer maintains BAC to Outperform. Target Price is $19; previously $21.","showOnAxis":true},{"date":new Date(2015,9,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BAC to Buy. Target Price is $18; previously $21.","showOnAxis":true},{"date":new Date(2016,0,19),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2015 Q4's earning $0.28 per share and revenue $19759MM. This beats analyst's estimated EPS $0.27, misses estimated revenue $20120MM.","showOnAxis":false},{"date":new Date(2016,0,20),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Sandler O'Neill upgrades BAC to Buy from Hold.","showOnAxis":false},{"date":new Date(2016,0,20),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Barclays maintains BAC to Equal-Weight. Target Price is $19; previously $20.","showOnAxis":true},{"date":new Date(2016,0,26),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BAC to Buy. Target Price is $17; previously $19.","showOnAxis":true},{"date":new Date(2016,0,29),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"CLSA upgrades BAC to Outperform.","showOnAxis":false},{"date":new Date(2016,1,25),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Credit Suisse maintains BAC to Outperform. Target Price is $18; previously $20.","showOnAxis":true},{"date":new Date(2016,10,15),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Guggenheim downgrades BAC to Neutral from Buy.","showOnAxis":true},{"date":new Date(2016,10,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Baird downgrades BAC to Neutral from Outperform.","showOnAxis":true},{"date":new Date(2016,10,29),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Keefe Bruyette & Woods upgrades BAC to Outperform from Market Perform.","showOnAxis":false},{"date":new Date(2016,10,30),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.075","showOnAxis":true},{"date":new Date(2016,10,30),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank maintains BAC to Hold. Target Price is $23; previously $17.5.","showOnAxis":true},{"date":new Date(2016,10,8),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Deutsche Bank downgrades BAC to Hold from Buy.","showOnAxis":true},{"date":new Date(2016,11,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Standpoint Research downgrades BAC to Hold from Buy.","showOnAxis":true},{"date":new Date(2016,11,21),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Atlantic Equities upgrades BAC to Overweight from Neutral.","showOnAxis":false},{"date":new Date(2016,2,1),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Atlantic Equities downgrades BAC to Neutral from Overweight.","showOnAxis":true},{"date":new Date(2016,2,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods maintains BAC to Outperform. Target Price is $19; previously $17.","showOnAxis":true},{"date":new Date(2016,2,2),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.05","showOnAxis":true},{"date":new Date(2016,3,14),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2016 Q1's earning $0.21 per share and revenue $19727MM. This meets analyst's estimated EPS $0.21, misses estimated revenue $20300MM.","showOnAxis":false},{"date":new Date(2016,3,17),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains BAC to Buy. Target Price is $16; previously $15.","showOnAxis":true},{"date":new Date(2016,3,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"JP Morgan maintains BAC to Overweight. Target Price is $16; previously $16.5.","showOnAxis":true},{"date":new Date(2016,4,16),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods downgrades BAC to Market Perform from Outperform. Target Price is $16; previously $17.","showOnAxis":true},{"date":new Date(2016,5,1),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.05","showOnAxis":true},{"date":new Date(2016,6,13),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Berenberg initiates coverage on BAC to Buy. Target Price is $15.","showOnAxis":true},{"date":new Date(2016,6,18),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2016 Q2's earning $0.36 per share and revenue $20621MM. This beats analyst's estimated EPS $0.33, beats estimated revenue $20520MM.","showOnAxis":false},{"date":new Date(2016,6,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Citigroup maintains BAC to Buy. Target Price is $17; previously $16.","showOnAxis":true},{"date":new Date(2016,6,19),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Keefe Bruyette & Woods maintains BAC to Market Perform. Target Price is $15; previously $14.","showOnAxis":true},{"date":new Date(2016,6,7),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Raymond James downgrades BAC to Market Perform from Outperform.","showOnAxis":true},{"date":new Date(2016,7,31),"type":"sign","text":"D","backgroundColor":"#ADD8E6","graph":"g1","description":"The Firm pays dividend $0.075","showOnAxis":true},{"date":new Date(2016,8,23),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"CLSA maintains BAC to Outperform. Target Price is $18; previously $17.","showOnAxis":true},{"date":new Date(2016,9,10),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Jefferies maintains BAC to Buy.","showOnAxis":true},{"date":new Date(2016,9,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"Compass Point initiates coverage on BAC to Neutral.","showOnAxis":true},{"date":new Date(2016,9,17),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2016 Q3's earning $0.41 per share and revenue $21863MM. This beats analyst's estimated EPS $0.33, beats estimated revenue $20940MM.","showOnAxis":false},{"date":new Date(2017,0,11),"type":"sign","text":"N","backgroundColor":"#ADD8E6","graph":"g1","description":"UBS downgrades BAC to Neutral from Buy. Target Price is $23; previously $24.","showOnAxis":true},{"date":new Date(2017,0,12),"type":"arrowUp","text":null,"backgroundColor":"#00CC00","graph":"g1","description":"Societe Generale upgrades BAC to Buy from Hold. Target Price is $31.5; previously $17.","showOnAxis":false},{"date":new Date(2017,0,13),"type":"sign","text":"K","backgroundColor":"#FFFF00","graph":"g1","description":"Before market open, BAC reports 2016 Q4's earning $0.4 per share and revenue $20224MM. This beats analyst's estimated EPS $0.38, misses estimated revenue $20990MM.","showOnAxis":false}];